Neuraminidase inhibitors-the story behind the Cochrane review

被引：58

作者：

Doshi, Peter ^{[1
]}

机构：

[1] MIT, Program Hist Anthropol Sci Technol & Soc, Cambridge, MA 02139 USA

来源：

BMJ-BRITISH MEDICAL JOURNAL | 2009年 / 339卷

关键词：

IMMUNIZATION PRACTICES ACIP; ADVISORY-COMMITTEE; ACUTE INFLUENZA; OSELTAMIVIR; RECOMMENDATIONS; PREVENTION; EFFICACY; SAFETY;

D O I：

10.1136/bmj.b5164

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1348 / 1351

页数：10

共 26 条

[21]

Johnson Kay, 2006, Morbidity and Mortality Weekly Report, V55, P1

[22]

STURCKE J, 2009, GUARDIAN 0816

[23] Amantadine, oseltamivir and zanamivir for the prophylaxis of influenza (including a review of existing guidance no. 67): a systematic review and economic evaluation [J].

Tappenden, P. ;

Jackson, R. ;

Cooper, K. ;

Rees, A. ;

Simpson, E. ;

Read, R. ;

Nicholson, K. .

HEALTH TECHNOLOGY ASSESSMENT, 2009, 13 (11) :1-+

[24] Assessment of Neuropsychiatric Adverse Events in Influenza Patients Treated with Oseltamivir A Comprehensive Review [J].

Toovey, Stephen ;

Rayner, Craig ;

Prinssen, Eric ;

Chu, Tom ;

Donner, Barbara ;

Thakrar, Bharat ;

Dutkowski, Regina ;

Hoffmann, Gerhard ;

Breidenbach, Alexander ;

Lindemann, Lothar ;

Carey, Ellen ;

Boak, Lauren ;

Gieschke, Ronald ;

Sacks, Susan ;

Solsky, Jonathan ;

Small, Ian ;

Reddy, David .

DRUG SAFETY, 2008, 31 (12) :1097-1114

[25] Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza - A randomized controlled trial [J].

Treanor, JJ ;

Hayden, FG ;

Vrooman, PS ;

Barbarash, R ;

Bettis, R ;

Riff, D ;

Singh, S ;

Kinnersley, N ;

Ward, P ;

Mills, RG .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (08) :1016-1024

[26]

Turner D., 2003, Health Technol Assess, V7, P1

← 1 2 3 →